Skip to content

Matteo Stravalaci

  • PhD student
  • Post Doc
  • Fondazione IRCCS Istituto Neurologico Carlo Besta
  • 16h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 1198CitationsNumber of citations received by Matteo's publications. Updated daily.

About

My main objectives are the development and characterization of new surface plasmon resonance-based immunoassay to recognize toxic oligomeric species involved in neurodegenerative disorders, such as Alzheimer's disease, and to discover potential compounds interfering with them

Recent publications

  • An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein

    • Stincardini C
    • Massignan T
    • Biggi S
    • et al.
    N/AReaders
    3Citations
  • Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity

    • Romeo M
    • Stravalaci M
    • Beeg M
    • et al.
    N/AReaders
    7Citations

Professional experience

Post Doc

Fondazione IRCCS Istituto Neurologico Carlo Besta

December 2016 - Present

PhD Student

Istituto Di Ricerche Farmacologiche Mario Negri

October 2012 - Present

Scholarship fellow

Istituto Di Ricerche Farmacologiche Mario Negri

April 2009 - June 2012(3 years)

Education

Master Degree in Industrial Biotechnology

University of Milan-Bicocca Department of Biotechnology and Biosciences

October 2006 - April 2009(3 years)

Istituto Di Ricerche Farmacologiche Mario Negri